Intel Capital looks set exit the marketing technology provider, which has filed to raise up to $100m on the New York Stock Exchange.

Lilly Asia Ventures took part in a $78m round for oncology therapy developer BH Med while gifting platform developer Snappy completed a $70m Hearst-backed series C.

JD.com has followed up the December flotation of its JD Health spinoff by listing its Tencent and China Life-backed logistics vehicle.

Vision Fund is the largest shareholder of freight services provider Full Truck Alliance, which is reportedly seeking a $20bn valuation when it floats.

The Comcast, PayPal and Rakuten-backed micro-investing service is merging with Nasdaq-listed Pioneer Merger Corp at a $2.2bn post-transaction valuation.

The Gilbarco Veeder-Root, Varley Group and Cigna-backed electric vehicle charging technology developer will list through a $1.2bn reverse merger deal.

Access Industries and Takeda scored exits as the oncology therapy developer floated at the top of its range in an upsized offering.

Zymergen has purchased Lodo Therapeutics, which is advancing Rockefeller research, for an undisclosed sum five years after the company raised its only funding round.

The GlaxoSmithKline and Celgene-backed immunotherapy developer has revealed its intention to float on the Nasdaq Global Market.

The Pfizer, GlaxoSmithKline, Novartis, AbbVie and Astellas-backed oncology therapy developer is set to go public through a reverse takeover.